To investigate mechanisms for increased malignant properties in
malignant melanomas by
ganglioside GD3,
enzyme-mediated activation of radical sources and subsequent mass spectrometry were performed using an anti-GD3 antibody and GD3-positive (GD3+) and GD3-negative (GD3-)
melanoma cell lines.
Neogenin, defined as a GD3-neighbored molecule, was largely localized in
lipid/rafts in GD3+ cells. Silencing of
neogenin resulted in the reduction of cell growth and invasion activity. Physical association between GD3 and
neogenin was demonstrated by immunoblotting of the immunoprecipitates with anti-
neogenin antibody from GD3+ cell lysates. The intracytoplasmic domain of
neogenin (Ne-ICD) was detected in GD3+ cells at higher levels than in GD3- cells when cells were treated by a
proteasome inhibitor but not when simultaneously treated with a γ-
secretase inhibitor. Exogenous GD3 also induced increased Ne-ICD in GD3- cells. Overexpression of Ne-ICD in GD3- cells resulted in the increased cell growth and invasion activity, suggesting that Ne-ICD plays a role as a transcriptional factor to drive malignant properties of
melanomas after cleavage with γ-
secretase. γ-
Secretase was found in
lipid/rafts in GD3+ cells. Accordingly, immunocyto-staining revealed that GD3,
neogenin, and γ-
secretase were co-localized at the leading edge of GD3+ cells. All these results suggested that GD3 recruits γ-
secretase to
lipid/rafts, allowing efficient cleavage of
neogenin. ChIP-sequencing was performed to identify candidates of target genes of Ne-ICD. Some of them actually showed increased expression after expression of Ne-ICD, probably exerting malignant phenotypes of
melanomas under GD3 expression.